How to Cite
Abstract
Rheumatic heart disease (RHD) represents one of the most significant yet preventable causes of cardiovascular morbidity and mortality worldwide. It develops as a chronic sequela of acute rheumatic fever (ARF), an autoimmune inflammatory reaction triggered by infection with Group A beta-hemolytic Streptococcus (GAS).
References
1. World Health Organization. WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease. Geneva: WHO; 2024.
2. World Health Organization. Rheumatic heart disease: fact sheet. Geneva: WHO; 2025.
3. Ali SKM. Implementing the World Health Organization Guidelines for Rheumatic Heart Disease in Highly Endemic Settings: Balancing Evidence with Reality. Glob Heart. 2026.
4. Kumar RK, Antunes MJ, Beaton A, et al. Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap: A Scientific Statement From the American Heart Association. Circulation. 2020;142(20):e337-e357.
5. Rwebembera J, Marangou J, Mwita JC, et al. 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease. Nat Rev Cardiol. 2024;21(4):250-263.
6. Alaska Department of Epidemiology. Investigation of an Increase in Acute Rheumatic Fever and Rheumatic Heart Disease. Epidemiology Bulletin. 2026;RR2026_01.
7. Medscape. Rheumatic Heart Disease Treatment & Management. Updated 2025.
8. Hirani K, Rwebembera J, Webb R, et al. Acute rheumatic fever. Lancet. 2025;405(10495):2164-2178.
9. American College of Cardiology. Contemporary Diagnosis and Management of Rheumatic Heart Disease. JACC. 2020.
10. Birru EM, Alene KA, Manning L, Batty KT, Moore BR. Severe adverse reactions to benzathine penicillin G in rheumatic heart disease: A systematic review and meta-analysis. PLoS One. 2025;20(5):e0322873.
This work is licensed under a Creative Commons Attribution 4.0 International License.
